US4055654AExpiredUtility
6,8-Di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid and derivative for the prevention of asthmatic symptoms
Est. expiryAug 25, 1990(expired)· nominal 20-yr term from priority
C07C 45/71C07C 45/46C07C 45/67C07D 307/12
43
PatentIndex Score
2
Cited by
7
References
4
Claims
Abstract
There are described certain mono-chromone-2-carboxylic acids of formula, ##STR1## having one substituent in the 5 or 6 position or having 2 or more substituents in the 5,6,7 or 8 positions. There are also described processes for making the compounds and pharmaceutical compositions, for the treatment of asthma, containing the compounds.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A composition useful for the prevention of asthmatic symptoms comprising an amount useful for the prevention of asthmatic symptoms of 6,8-di-t-butyl-4-oxo-4-H-1-benzopyran-2-carboxylic acid or a pharmaceutically acceptable salt, lower alkyl ester, ester with a di-lower alkylamine substituted lower alkanol, bis ester with a di-(hydroxy lower alkyl) ether or unsubstituted amide thereof, as active ingredient, in combination with a pharmaceutically acceptable carrier.
2. A composition according to claim 1 comprising from 0.17 to 600 mg. of active ingredient in unit dosage form.
3. A composition according to claim 1 comprising an effective amount of 6,8-di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid.
4. A method for inhibiting the symptoms of asthma in a patient having asthma which comprises administering to said patient, an effective amount of 6,8-di-t-butyl-4-oxo-4H-1-benzopyran-2-carboxylic acid or a pharmaceutically acceptable alt, lower alkyl ester with a di-lower alkylamine substituted lower alkanol, bis ester with a di-(hydroxy lower alkyl) ether or unsubstituted amide thereof, as active ingredient, in combination with a pharmaceutically acceptable carrier.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.